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Introduction
Increased intracranial pressure (ICP) results in cerebral blood
flow decrease and cerebral edema formation. Correction of
intracranial hypertension (ICH) is one of the most important
goals of intensive care in patients with severe traumatic brain
injury (TBI).
Objectives
To determine the effects of L-lysine aescinat on ICP in
patients with severe TBI.
Methods
Twenty patients with TBI and Glasgow coma scale below
9 enrolled in the study. Mean age was 39.3 ± 13.6 years,
male/female - 18/2. All patients were operated: 6 patients
underwent craniotomy and intracranial hematoma remov-
ing; 11 - decompressive craniotomy and intracranial
hematoma removing. In 3 patients only ICP-sensor was
implanted. ICP-monitoring was used in all patients. Ten
patients were randomized to L-lysine aescinat treatment
(daily dose of 20 ml for 7 days after surgery) (study group),
10 - to standard therapy (control group). We perfomed a
comparative analysis of the mean ICP and the incidence of
ICH within 7 days after surgery in the study and control
groups.
Results
The length of ICP monitoring was 6.4 ± 3.7 days: in the
control group - 7.6 ± 4.9 days, in the study group - 5.2 ±
1.4 days. Mean intracranial pressure (mmHg) was less in
the study group as compared to patients in the control
group: 1st day - 14.3 ± 5.9 (n = 136) vs 17.0 ± 3.8 (n =
156), 2nd day - 15.7 ± 5.4 (n = 158) vs 17.4 ± 4.6 (n = 141),
3rd day - 17.0 ± 6.5 (n = 144) vs 17.1 ± 6.9 (n = 161),
4th day - 17.3 ± 9.5 (n = 163) vs 20.7 ± 5.9 (n = 135),
5th day - 14.6 ± 5.9 (n = 83) vs 18.9 ± 5.6 (n = 136),
6th day - 12.8 ± 4.5 (n = 79) vs 15.9 ± 6.4 (n = 66), 7th day
- 12.4 ± 8.6 (n = 56) vs 14.4 ± 7.6 (n = 95). The number of
intracranial hypertension episodes was higher in the con-
trol group compared with patients who received L-lysine
aescinat: 1st day - 4.2 ± 4.2 vs 2.8 ± 3.3, 2nd day - 6.5 ± 5.1
vs 3.0 ± 2.5, 3rd day - 6.0 ± 8.0 vs 2.6 ± 3.3, 4th day - 9.6 ±
10.1 vs 3.4 ± 3.8, 5th day - 7.4 ± 8.2 vs 2.6 ± 3.7, 6th day -
7.3 ± 8.6 vs 0.4 ± 0.9, 7th day - 5.0 ± 9.3 vs 1.3 ± 1.3.
Conclusions
L-lysine aescinat treatment in patients with severe trau-
matic brain injury is accompanied by reduction of mean
intracranial pressure and the number of intracranial
hypertension episodes.
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